$TORNTPHARM

$TORNTPHARM Torrent Pharmaceuticals is one of India's leading pharmaceutical companies with a strong presence in: Cardiac Diabetes CNS Gastrointestinal Women's healthcare The company earns a significant portion of its revenue from India while also having operations in Brazil, Germany and the US, giving it a diversified revenue base. Positives ✅ Strong Domestic Franchise One of the leaders in chronic therapies. Chronic medicines generally provide stable and recurring demand. ✅ High Profitability Consistently healthy EBITDA margins. Strong return ratios compared to many pharma peers. ✅ Strategic Acquisition The acquisition of JB Chemicals & Pharma strengthens Torrent's domestic market position, expands its therapy portfolio, and adds a CDMO business. Analysts expect meaningful cost synergies over the next few years. ✅ Healthy Cash Generation Strong operating cash flow supports expansion and future investments. Risks ⚠ Premium Valuation Torrent Pharma trades at a premium valuation versus its historical averages, so future returns depend on earnings growth continuing to justify that premium. ⚠ Integration Risk The successful integration of JB Chemicals is an important execution challenge. ⚠ US Market Pricing Pressure Generic drug pricing pressure in the US remains a sector-wide risk.